BETTENA WITHERSPOON: Open Payments
NPI 1073879995 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 12 payments from 10 companies in 2025. Trend: 2023 $619 · 2024 $481 · 2025 $310
Food & beverage: $250Consulting: $60
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 2 | $64 |
| Biogen, Inc. | 1 | $60 |
| Lilly USA, LLC | 2 | $34 |
| Lundbeck LLC | 1 | $29 |
| CSL Behring | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
Products named: QUTENZA, TYSABRI, VYEPTI, Hizentra, SAPHNELO, KEYTRUDA QLEX, ENTYVIO, AMYVID.
Industry payments across TN — which companies pay providers there.
